Related Experiment Video
Updated: May 25, 2026

10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
A cell-based backup to speed up pandemic influenza vaccine production
Min-Shi Lee1, Alan Yung-Chih Hu
1National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, 35 Keyan Road, Zhunan, Miaoli 350, Taiwan. minshi@nhri.org.tw
Trends in Microbiology
|January 20, 2012
Abstract:
Influenza vaccines are currently produced through egg-based methods, with one drawback being that this system is slow to respond to the surging global demand during an influenza pandemic. Alternative influenza vaccine production strategies, such as using a cell-based strategy, should be considered in pandemic situations.

